Table 1.
The correlation between different ANKRD22 expression levels andclinicopathological features of patients with ovarian cancer
| Characteristics | All patients | ANKRD22 Expression | P value | |
| Low | High | |||
| No | 20 | 7 | 13 | |
| Age (years) | 0.630 | |||
| <55 | 9 | 3 | 6 | |
| ≥55 | 11 | 4 | 7 | |
| Pathological type | 0.374 | |||
| Non-epithelial | 9 | 2 | 7 | |
| Epithelial | 11 | 5 | 6 | |
| Diffentiation | 0.651 | |||
| Poor differentiated | 7 | 3 | 4 | |
| Well differentiated | 13 | 4 | 9 | |
| NLR | 0.044 | |||
| <2.14 | 7 | 0 | 7 | |
| ≥2.14 | 13 | 7 | 6 | |
| MLR | ||||
| <0.24 | 5 | 2 | 3 | |
| ≥0.24 | 15 | 5 | 10 | |
| PLR | 0.114 | |||
| <146.11 | 5 | 0 | 5 | |
| ≥146.11 | 15 | 7 | 8 | |
| Recurred | 0.031 | |||
| Yes | 5 | 4 | 1 | |
| No | 15 | 3 | 12 | |
| FIGO stage | 0.044 | |||
| I–III | 7 | 0 | 7 | |
| IV | 13 | 7 | 6 | |
FIGO, International Federation of Gynecology and Obstetrics; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-tolymphocyte ratio; PLR, platelet-to-lymphocyte ratio.